NCT02667704View on ClinicalTrials.gov

Influence of Bosentan on the Pharmacokinetics of Nintedanib

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Healthy
Interventions
DRUG

Bosentan

DRUG

Nintedanib

Trial Locations (1)

Unknown

Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY